文献速递糖尿病肥胖与代谢综合征

牙周炎治疗对肥胖与非肥胖个体肠促胰岛素轴的影响:队列研究

Effect of Treatment of Periodontitis on Incretin Axis in Obese and Nonobese Individuals: A Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该队列研究在伦敦国王学院牙科医院开展,评估非手术牙周治疗对肥胖与正常体重非糖尿病牙周炎患者肠促胰岛素轴的影响。基线时肥胖者牙周参数更差且hs-CRP、胰岛素、GLP-1更高;治疗后两组GLP-1与GIP在6个月时均显著升高,肥胖组GLP-1升高更快,胰岛素与胰高血糖素无变化。

要点

  • 非手术牙周治疗可使肥胖与非肥胖牙周炎患者6个月时GLP-1与GIP显著升高。
  • 肥胖患者基线hs-CRP、胰岛素、GLP-1更高且牙周治疗反应较差。
  • 治疗后胰岛素与胰高血糖素在2和6个月均无显著变化。

核心结论

  • 非手术牙周治疗与非肥胖及肥胖患者GLP-1和GIP水平升高相关,肥胖者GLP-1升高更迅速,可能对这些个体的代谢风险有积极意义。

研究设计与样本

  • 队列研究,在伦敦国王学院牙科医院与研究所开展,纳入肥胖与正常体重指数的非糖尿病牙周炎患者,在基线、治疗后2个月和6个月检测代谢指标。

主要发现

  • 基线时肥胖者牙周参数较非肥胖者更差,并伴有更高的循环hs-CRP、胰岛素和GLP-1水平。
  • 肥胖组对牙周治疗的反应较差,hs-CRP或丙二醛无显著变化。
  • 治疗后胰岛素和胰高血糖素在2和6个月均无变化,而GLP-1和GIP在两组6个月时均显著升高。
  • GLP-1在肥胖参与者中升高更快,GIP的升高在两组各访视点趋势相似。

临床怎么用

  • 对肥胖合并非糖尿病牙周炎患者,非手术牙周治疗可能通过升高GLP-1和GIP带来代谢获益。
  • 肥胖患者牙周治疗反应较差,需关注其系统性炎症和氧化应激标志物未见改善的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Periodontitis confers an increased risk of developing type 2 diabetes and, in patients with obesity, it might interfere with the incretin axis. The effect of periodontal treatment on glucoregulatory hormones remains unknown. OBJECTIVE: To evaluate the effect of periodontal treatment on incretin axis in obese and lean nondiabetic individuals. SETTING: King's College Dental Hospital and Institute, London, UK. PARTICIPANTS AND METHODS: The metabolic profile of obese and normal-body-mass-index individuals affected by periodontitis was studied at baseline, 2, and 6 months after intensive periodontal treatment, by measuring plasma insulin, glucagon, glucagon-like peptide-1(GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) and markers of systemic inflammation and oxidative stress. MAIN OUTCOME MEASURE(S): Circulating levels of incretins and inflammatory markers. RESULTS: At baseline, periodontal parameters were worse for obese than nonobese; this was accompanied by higher levels of circulating high-sensitivity C-reactive protein (hs-CRP), insulin, and GLP-1. The response to periodontal treatment was less favorable in the obese group, without significant variations of hs-CRP or malondialdehyde. Glucoregulatory hormones changed differently after treatment: while insulin and glucagon did not vary at 2 and 6 months, GLP-1 and GIP significantly increased at 6 months in both groups. In particular, GLP-1 increased more rapidly in obese participants, while the increase of GIP followed similar trends across visits in both groups. CONCLUSIONS: Nonsurgical treatment of periodontitis is associated with increased GLP-1 and GIP levels in nonobese and obese patients; changes in GLP-1 were more rapid in obese participants. This might have positive implications for the metabolic risk of these individuals.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Suvan J, Masi S, Harrington Z, et al. Effect of Treatment of Periodontitis on Incretin Axis in Obese and Nonobese Individuals: A Cohort Study. J Clin Endocrinol Metab. 2021. PMID: 33084864. doi:10.1210/clinem/dgaa757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。